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Mouse model systems have proven very useful in the study of human birth 
defects.  Such is the case for holoprosencephaly (HPE), which results from improper 
division of the forebrain.  One gene that has been associated with human cases of HPE 
is TG-interacting factor (TGIF).  This gene was first discovered through its ability to bind 
retinoid X receptor response elements and repress retinoid X receptor-α mediated 
transcription.  Breeding mice possessing a targeted null allele of Tgif reveals that Tgif 
mutations alone do not result in HPE.  Instead, Tgif mutations may be required in 
conjunction with other genetic mutations or environmental factors in order to cause 
HPE.  Previous studies showing that prenatal exposure to retinoic acid (RA) results in 
HPE sparked interest in the function of Tgif in RA signaling.  Teratogenesis experiments 
demonstrate that Tgif mutations result in an increased susceptibility to HPE 
development through overexposure to all-trans retinoic acid (ATRA).  These results 
represent a novel cooperation between environmental and genetic factors in the 
etiology of HPE.  Because Tgif has also been implicated in transforming growth factor β 
(TGF-β) signaling, similar teratogenesis experiments were performed with mice 
harboring null mutations in Smad2, a TGF-β signal transducer that physically interacts 
with Tgif.  Heterozygous loss of Smad2 also results in a predisposition to developing 
HPE through ATRA teratogenesis.  Analyses using a retinoid responsive lacZ reporter 
gene provide evidence that embryonic day 9.5 and 10.5 embryos with Tgif or Smad2 
mutations maintain an increased level of RA signaling in the forebrain.  These 
observations support Tgif as a mediator of RA signaling during development and imply 
a novel interaction between RA and TGF-β signaling.
 i  
 
Table of Contents 
 
            Page 
Abstract  …..……………………………………………………………….………… i 
List of Tables  ………………………………………………………………………. iv 
List of Figures  ……………………………………………………….……………… v 
List of Abbreviations  ………………………………………………………………. vi 
 
Chapters 
1  Introduction……………………………………………………………………….. 1 
 
1.1  Forebrain formation and holoprosencephaly…………………….. 1 
1.2  Retinoic acid signaling………..………….…………………………. 3 
1.3  TGF-β signaling……………………………………………………… 4 
 
2  Tgif and TGF-β signaling interactions in the formation of holoprosencephaly 10 
 
2.1  Tgif ; Smad2 mutant embryos display holoprosencephaly……… 11 
2.2  Tgif ; Smad3 mutant embryos fail to exhibit abnormalities……… 12 
2.3 Materials and Methods……………………………………………… 13 
2.3.1 Mice and Matings……………………………………………. 13 
2.3.2 Genotyping…………………………………………………… 13 
 
3  RA teratogenesis sensitivity in Tgif and Smad2 mutant embryos…………… 17 
 
3.1  Retinoic acid teratogenesis of Tgif mutants………………………. 17 
 3.2  Retinoic acid teratogenesis of Smad2 mutants………………….. 19 
3.3 Materials and Methods……………………………………………… 19 
3.3.1 Teratogenic application of retinoic acid…………………… 19 
 
4  RA signaling levels in Tgif and Smad2 mutant embryos…………………….. 23 
 
4.1  Use of a retinoic acid responsive lacZ reporter to visualize retinoid 
signaling in Tgif mutants……………………………………………. 23 
 4.2  Quantification of β-galactosidase expression in Smad2 mutants. 27 
4.3 Materials and Methods……………………………………………… 28 
4.3.1 Whole mount visualization of β-galactosidase expression. 28 
4.3.2 Quantification of β-galactosidase expression…………….. 28 
 
 ii  
           Page 
5  Mechanisms of Smad2 repression of retinoic acid signaling………………… 32 
  
 5.1  Use of immunoprecipitation to assess physical interactions between  
Smad2 and RAR-γ proteins ………………………………………... 33 
5.2  Use of semi-quantitative RT-PCR to measure Smad2 regulation of RAR 
and RXR transcription………………………………………………. 33 
5.3  Use of a retinoic acid responsive luciferase reporter to measure the affect 
of Smad2 on retinoid regulated transcription…………………….. 34 
5.4 Materials and Methods……………………………………………… 35 
5.4.1 Cell Culture…………………………………………………… 35 
5.4.2 Transient cell transfections…………………………………. 35 
5.4.3 Immunoprecipitation and western blotting………………… 36 
5.4.4 Semi-quantitative RT-PCR…………………………………. 36 
5.4.5 Luciferase assays……………………………………………. 37 
 
6  Discussion…………………………………………………………………………. 39 
 
Works Cited…………………………………………………………………………. 41 
 
 iii  
 
List of Tables 
            Page 
2.1 Evaluation of E10.5 Smad3; Tgif embryos………………………………….. 15 
2.2 Evaluation of E11.5 Smad3; Tgif embryos………………………………….. 15 
3.1 Summary of E10.5 Tgif embryos exposed to ATRA.………………………….. 20 
4.1 Comparison of endogenous levels of RA signaling in E9.5 and E10.5 Tgif mutant 
embryos……………………………………………………………………………… 29 
 
5.1 List of primers used for semi-quantitative RT-PCR…………………………. 38 
 
 iv  
 
List of Figures 
            Page 
 
1.1 Mammalian neurulation………………………………………..………………. 7 
1.2 Mammalian prosencephalon development………………………………….. 7 
1.3 Abnormalities associated with HPE.…………………………….……..…….. 8 
1.4 Retinoic acid signaling pathway………………………………….…….….…. 8 
1.5 TGF-β signaling pathway……………………………………………………… 9 
1.6 Smad protein structure………………………………………………………… 9 
 
 
2.1 Tgif expression pattern at E8.5 and E9.5……………………………….….... 16 




3.1Tgif crosses for teratogenesis experiments………………………….…..…… 21 
3.2 Phenotypes exhibited by E10.5 embryos exposed to ATRA.………...……. 21 
3.3 Frequency of ATRA induced abnormalities…………………………..……… 22 
3.4 Summary of E9.5 Smad2 embryos exposed to ATRA………………..……. 22 
 
 
4.1 Retinoic acid responsive lacZ reporter allele……………………….……….. 29 
4.2 Embryos carrying the RA responsive β-galactosidase allele after lacZ staining 30 
4.3 Second representation of teratogenesis results…………………………….. 30 
4.4 Comparison of endogenous levels of RA signaling in E9.5 and E10.5 Smad2 mutant 
embryos………………………………………………………………………………. 31 
  





 v  
 
Abbreviations 
 9cisRA  9-cis retinoic acid 
ATRA   all-trans retinoic acid 
 BMP   bone morphogenic protein 
 co-Smad  common-mediator Smad 
 DMEM  Dulbecco’s modified Eagle’s medium 
E   embryonic day 
FCS   fetal calf serum 
 HPE   holoprosencephaly 
 I-Smad  inhibitory Smad 
NLS   nuclear localization sequence 
PBS   phosphate buffered saline 
R-Smad  receptor-regulated Smad 
RA   retinoic acid 
 RAR   retinoic acid receptor 
 RARE   retinoic acid receptor response element 
 RXR   retinoid X receptor 
 RXRE   retinoid X receptor response element 
 SHH   Sonic Hedgehog 
TGF-β  transforming growth factor beta 
 TGIF   TG-interacting factor 
 vi  




 The first step to preventing any human ailment is understanding the mechanism 
through which it develops.  Genetic diseases are defined as ailments due to DNA 
mutations or cooperation between mutations and environmental influences.  There are 
two main strategies for elucidating which specific mutations are responsible for a 
genetic disease.  First, one may start with a phenotypic subject, search their DNA 
sequence for mutations or deletions, and correlate them with the DNA sequences of 
other affected subjects.  The second strategy involves altering the genome of a subject 
and observing whether the alteration is sufficient for causing the disease.  This second 
strategy, however, remains unethical to use on human subjects.  Instead, many 
researchers turn to mice for these purposes because of their genetic malleability, 
relatively short generation time, and high degree of comparability to humans.   
Mouse strains harboring mutations in genes such as Tgif , Smad2, or Smad3 not 
only aid in understanding the mechanisms of genetic disease, but also reveal functions 
of the targeted gene in proper embryonic development.   
 
1.1 Forebrain formation and holoprosencephaly 
 Nervous system development in humans is similar to that in mice and can be 
thought of as a specified sequence of events.  After initial patterning, the neural plate 
invaginates and the sides fuse together forming a cylindrical structure called the neural 
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tube, which will later give rise to the central nervous system (Figure 1.1).  This occurs 
around days 24-26 of human gestation and embryonic days 8.0 to 9.0 (E8.0-E9.0) of 
mouse gestation (Reviewed in [1]).  Next, the anterior portion of the neural tube begins 
to form the prosencephalon, which will eventually become the forebrain.  Around week 
5-6 in humans and E9.0 –E10.0 in mice, the prosencephalon undergoes 3 cleavages: 
horizontal, transverse, and sagittal.  The horizontal cleavage causes formation of paired 
optic vesicles, olfactory bulbs, and tracts.  The transverse cleavage separates the 
diencephalon and the telencephalon.  Finally, the sagittal cleavage divides the 
telencephalon into two portions, which will eventually form the right and left 
hemispheres of the forebrain (Reviewed in [1]) (Figure 1.2).  The events that occur 
during the patterning of the prosencephalon influence the formation of the forebrain and 
certain facial features.  Therefore, many birth defects that affect the forebrain and face 
begin at this stage.  A few examples of these are aprosencephaly, atelencephaly, and 
holorosencephaly (HPE).  Although the least severe of the three, HPE is the most 
common of these birth defects, occurring in 1 out of every 250 conceptions [2].  
However, due to the high rate of lethality, HPE is only seen in 1 out of every 16000 live 
births [3].  The majority of HPE cases result from a failure of the sagittal cleavage of the 
telencephalon to initiate or complete (Reviewed in [1]).  This leaves the hemispheres of 
the forebrain in a fully to partially fused state, characteristic of HPE.  Other anomalies 
that may accompany HPE include cyclopia, mental retardation, cleft palate, and minor 
midline abnormalities [4] (Figure 1.3).  Cases of HPE are classified into one of three 
groups: alobar, semilobar, or lobar, ranging from most to least severe [5].   
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 The etiology of HPE is very diverse, containing both genetic and environmental 
factors.  Currently there are at least 12 human genetic loci associated with HPE and 11 
genes including Sonic Hedgehog (SHH) and TGIF [6].  SHH is expressed in the ventral 
midline of the developing forebrain [7] and is required for proper formation of brain, 
eyes, somites, spinal cord, craniofacial structures, and limbs [8].  Moreover, SHH 
mutations in humans result in HPE [9, 10], and mice with targeted null alleles of Shh 
display limb defects, midline defects, abnormal forebrain formation, and cyclopia [10].  
TGIF was first characterized, using a human liver cDNA expression library, for its ability 
to bind the cellular retinol-binding protein II (CRBPII) promoter sequence.  The specific 
motif recognized by TGIF overlaps the retinoid X receptor response element (RXRE) 
contained in the CRBPII promoter.  In this context TGIF was found to reduce retinoid X 
receptor-α (RXRα) mediated transcriptional activation through direct competition for 
binding to the RXRE site [11].   TGIF’s involvement in the development of HPE was 
identified through analysis of chromosomal deletions in patients displaying HPE [12].  
Alterations of transforming growth factor β (TGF-β) signaling have also been associated 
with HPE-like abnormalities in mice and zebrafish (reviewed in [6]).  Environmental 
causes of HPE include ethyl alcohol, cyclopamine, and retinoic acid (reviewed in [13]). 
 
1.2 Retinoic acid signaling  
Retinoic acid (RA), a biological derivative of vitamin A, performs a vital role in 
many aspects of embryonic development including limb formation, specification of the 
anterior-posterior axis, skeletal development [14], and cellular differentiation (reviewed 
in [15]).  The great diversity of functions carried out by RA signaling is better understood 
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through its signaling mechanisms.  Due to its small molecular weight and non-polarity, 
RA is able to permeate cell membranes unaided.  It may also be synthesized from 
vitamin A (reviewed in [16]).  Once inside the cell, the various forms of RA preferentially 
bind one of two nuclear receptors, the retinoic acid receptor (RAR) or the retinoid X 
receptor (RXR) (Figure 1.4).  All-trans RA (ATRA) and 9-cis RA (9cisRA) are able to 
bind and activate RARs, whereas only 9cisRA is able to activate RXRs (reviewed in 
[15]).  Once activated, RXR preferentially heterodimerizes with an activated RAR, but 
may also homodimerize with an RXR, in order to regulate transcription of target genes.  
The sequence specific binding motifs recognized by the hetero/homodimers usually 
contain an exact repeat of PuG(G/T)TCA or a close variation, which are separated by 1, 
2, or 5 basepairs (reviewed in [15]).  Adding further to the functional diversity of retinoid 
signaling, the RAR and RXR families each consist of three isoforms (α,β,γ) and each 
isoform contains at least two different splice variants, totaling 8 RAR proteins and 6 
RXR proteins.  The resulting 48 possible heterodimers and numerous homodimers help 
to explain the wide role that retinoid signaling plays in embryonic development 
(reviewed in [15]).  
 
1.3 TGF-β signaling 
TGF-β signaling plays an important role in development as well.  Depending on 
the context, TGF-β signaling can cause cellular proliferation, apoptosis, or 
differentiation, and maintains a vital function in gastrulation and dorsoventral patterning 
[17].  Perturbations in TGF-β signaling have even been associated with murine cases of 
HPE-like cyclopia (reviewed in [6]).  The TGF-β superfamily contains many activators 
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such as TGF-β ligands, nodal, activins, and bone morphogenic proteins (BMPs), each 
signaling through a set of serine/threonine receptors named TGF-β receptor type I and 
type II (Figure 1.5) (reviewed in [18]).   Upon binding the type II receptor, the resulting 
ligand-receptor complex recruits a type I receptor and subsequently phosphorylates it 
(reviewed in [18]).  The activated type I receptor can then activate a number of Smad 
proteins to relay the signal to the nucleus.  The Smads are a diverse group of proteins 
including 8 known members, Smad1 through Smad8.  There are three types of Smads: 
inhibitory Smads (I-Smads), common-mediator Smad (co-Smad), and receptor-
regulated Smads (R-Smads).  I-Smads include Smad6 and Smad7, and the co-Smad is 
Smad4.  R-Smads are divided into two subgroups by ligand specificity; Smad2 and 
Smad3 are activated by TGF-β ligands, activins, or nodal, whereas Smad1, Smad5, and 
Smad8 are activated by BMPs (reviewed in [18]).  The R-Smads and co-Smad each 
contain conserved MH1 and MH2 domains (Figure1.6).  The MH1 domain carries DNA 
binding capabilities in all but Smad2, in addition to a nuclear localization sequence 
(NLS) with the exception of Smad4 (reviewed in [18]).  The MH2 domain contains the 
serine-rich activation site and provides the ability to complex with other Smad proteins 
as well as the TGF-β receptors.  Once the type I receptor is activated, it phosphorylates 
an R-Smad, which then complexes with Smad4.  Upon phosphorylation, conformational 
changes in the R-Smad protein structure open the NLS and allow translocation into the 
nucleus (reviewed in [18]).  It is this point in the pathway where the I-Smads are able to 
produce their inhibitory effects.  Because they retain the MH2 domain and its protein 
interaction capabilities, they can compete with R-Smads for binding of the TGF-β 
receptors (reviewed in [18]).   
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Once the R-Smad/Smad4 complex has entered the nucleus it recognizes specific 
DNA sequences and recruits transcriptional mediators such as CBP/p300.  These 
acetyltransferases loosen the DNA chromatin structure and promote gene transcription 
(reviewed in [18]).  However, other mediators such as Tgif, Ski, and c-Jun [19-21] can 
recruit histone deacetylases, which tighten the DNA structure and prevent gene 
transcription.  My study focuses on Tgif specifically.  Although discovered for its activity 
in retinoic acid signaling, Tgif can also be recruited by and bind to Smad2.  It is a 
homeodomain protein, which refers to a relatively conserved sequence of amino acids 
called the homeodomain and typically confers involvement in transcriptional activation 
or repression [22].   
 6  
  
Figure1.1 Mammalian neurulation.  As shown above, the Neural plate invaginates and the 
sides converge to form the Neural tube.  This occurs around days 24-26 of human gestation and 












Figure1.2 Mammalian prosencephalon development.  During weeks 5 and 6 of human 
gestation, the prosencephalon undergoes three cleavages.  The horizontal cleavage forms the 
optic vesicles, olfactory bulbs, and tracts.  The transverse cleavage separates the diencephalon 
and the telencephalon.  The sagittal cleavage divides the telencephalon into right and left 
hemispheres.  Altered from [23]. 









Figure1.3 Abnormalities associated with HPE.  (A,B) More severe cases exhibit cyclopia 
and a proboscis, which is present above the eye.  Less severe cases exhibit minor midline 



























Figure1.4 Retinoic acid signaling pathway.  Two forms of retinoic acid, 9-cis (9cisRA) and 
all-trans (ATRA), enter the cell and activate retinoid receptors through direct binding.  9cisRA 
may activate either the retinoic acid receptor (RAR) or the retinoid X receptor (RXR), where 
ATRA activates only the RAR.  Activated receptors then homodimerize or more commonly 
heterodimerize as depicted here. Finally, the receptor complexes activate target gene 
transcription by recognizing the appropriate retinoid response elements.  Tgif is able to compete 
for binding of the retinoid X receptor response element (RXRE) in order to prevent RA 


















Figure1.5 TGF-β signaling pathway.  Extracellular ligands bind the TGF-β type II receptor, 
which becomes activated and recruits a TGF-β type I receptor.  The receptor complex then 
activates R-Smads such as Smad2.  The co-Smad, Smad4, then chaperones the R-Smad into 
the nucleus where the Smad complex associates with co-activators or co-repressors like TGIF 
to regulate target gene transcription. Taken from [6]. 

























Figure1.6 Smad protein structure.  Except for Smads 6 and 7, the Smad proteins all contain 
conserved MH1 and MH2 domains connected by a linker region.  The MH1 domain carries a 
nuclear localization sequence (NLS) in all but Smad4.  It also encodes a DNA binding domain 
(DBD) in all but Smad2.  The MH2 domain contains a serine-rich activation site, and facilitates 
protein-protein interactions. 






Many genes have multiple functions, such as the Drosophila gene Dichaete.  
This gene has been found to function in fly segmentation, development of the central 
nervous system, brain, and hindgut, as well as post-embryonic development [24-26].  
Because homozygous null mutations of the Dichaete gene are lethal, its full range of 
functions must be deduced through means other than null mutations.  These methods 
typically include the use of hypomorphic alleles, artificially regulated alleles, or 
combining genetic mutations of related genes.  A similar situation exists with the murine 
gene Smad2.  Smad2 homozygous null mice (Smad2 -/-) are lethal before E8.5, while 
95% of mice heterozygous for the Smad2 null mutation (Smad2 +/-) show no phenotype 
[27, 28].  The remaining 5% display gastrulation defects at E9.5 [28].  The Smad2 -/- 
embryos also fail to gastrulate and therefore suggest a role for Smad2 during 
gastrulation [27], but unfortunately it also means that the functions of Smad2 cannot be 
deduced past E9.5 through use of a Smad2 null mutation alone.  For this reason, Ye Liu 
of the Weinstein laboratory bred Smad2 and Smad3 mutant strains together.  Although 
Smad2 +/- mice and Smad3 +/- mice are both viable, 51% of Smad2 +/-; Smad3 +/- mice 
exhibit embryonic lethality.  Furthermore, over 82% of Smad2 +/-; Smad3 +/- embryos 
survive past E8.5, and 44% of E9.5 - E10.5 embryos exhibit craniofacial or midline 
defects such as HPE [28].  These results allow Liu et al. to conclude that Smad2 and 
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Smad3 function in endodermal specification and migration, leading to proper 
craniofacial and midline patterning [28].   
 
2.1 Tgif ; Smad2 mutant embryos display holoprosencephaly 
To further elucidate the role of Smad2 during murine development, Dr. Tessa Carrel 
of the Weinstein laboratory combined Smad2 mutations with null mutations in the 
murine gene Tgif.  Tgif was chosen because of its interaction with Smad2 and Smad3 in 
TGF-β signaling, and more importantly, its connection with human cases of HPE [29].  
The Tgif mutant strain was obtained from Dr. David Wotton at the University of Virginia.  
Breeding of Tgif heterozygotes produces live born pups in mendelian ratios, and Tgif -/- 
mice are viable and fertile (data not shown).  To confirm the successful targeted 
disruption of the gene, whole mount in situ hybridization analysis was performed on 
E9.5 Tgif -/- embryos and found to have no Tgif expression relative to wild type embryos 
(Maria Festing unpublished data).  Whole mount analysis of wild type embryos at E8.5 
and E9.5 reveals Tgif expression along the anterior edge of the developing 
telencephalon at E8.5 and through out the prospective forebrain at E9.5 (Maria Festing 
submitted) (Figure 2.1).  These expression patterns make Tgif an excellent candidate 
for involvement in the occurrence of holoprosencephaly.  
The combination of Smad2 and Tgif null alleles again produced embryonic lethality 
in the double heterozygous mice as well as Smad2+/-; Tgif -/- mice.  Also as before, 
craniofacial defects such as HPE were observed in E9.5 - E10.5 embryos (Dr. Tessa 
Carrel unpublished data).  However, upon further investigation, the basis for 
holoprosencephalic defects appeared to differ between Smad2; Smad3 and Smad2; 
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Tgif embryos.  Using whole mount in situ analysis, it was determined that Smad2 +/-; 
Smad3 +/- embryos displaying midline abnormalities show a reduced rostral expression 
of Shh, Otx2, and Fgf8, each involved in the development of the forebrain or midbrain 
structures [28].  Conversely, abnormal Smad2 +/-; Tgif +/- and Smad2 +/-; Tgif -/- embryos 
only show a loss of rostral expression of Otx2 and display no change in Shh, Fgf8, or 
Zic2 expression (Dr. Tessa Carrel unpublished data).  These differences led to the 
conclusion that each combination of mutations causes HPE through different 
mechanisms.   
 
2.2 Tgif ; Smad3 mutant embryos fail to exhibit abnormalities 
 Another approach to determine the role of Tgif and Smad mutations in the 
causation of HPE was to cross the Tgif null and Smad3 null strains.  Because Smad3 +/-; 
Tgif +/- and Smad3 +/-; Tgif -/- mice are both viable and fertile, I was able to design 
crosses to obtain embryos of all allelic combinations of these two genes.  Initially, 130 
embryos were observed at E10.5, and a specific midbrain and hindbrain defect (Figure 
2.2) was observed at an average rate of 10% over all genotypes observed (Table 2.1).  
A smaller percentage of other various midline abnormalities were also seen (Table 2.1).  
The nature of the midbrain and hindbrain phenotype warranted ruling out the possibility 
of it being a dissection artifact.  To further investigate this phenotype, 53 embryos from 
similar crosses were observed at E11.5, a stage where embryos are larger and easier 
to dissect.  At E11.5, no abnormalities were found when 8 to 9 were expected according 
to the percentage seen in E10.5 embryos (Table 2.2).  Using a χ2 test, the P value 
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obtained for the E11.5 embryos is p<0.005, suggesting that these results are significant 
and the combination of Tgif and Smad3 mutations does not confer an overt phenotype. 
 
2.3 Materials and Methods 
 
2.3.1 Mice and Matings 
Mice carrying either Smad3 [30] or Tgif mutations were intercrossed and the 
resulting progeny were used to obtain embryos of the following genotypes: Smad3 +/+; 
Tgif +/-, Smad3 +/+; Tgif -/-, Smad3 +/-; Tgif +/-, Smad3 +/-; Tgif -/-, Smad3 -/-; Tgif +/-, or 
Smad3 -/-; Tgif -/-.  To study embryonic development, female mice were paired with 
males and examined daily for vaginal plugs.  The morning on which plugs were seen 
was assumed to correspond to E0.5.  At the appropriate stage of development, the 
embryos were dissected from their maternal decidua in 1X phosphate buffered saline 
(PBS).   Extraembryonic membranes were removed, retaining the yolk sack for 
genotyping.  Evaluation of embryonic phenotypes was preformed using a Zeiss Stemi 
SVII Apo dissecting microscope.  Embryos were then photographed with an MTI 3CCD 
digital camera and Scion Series 7 software. 
 
2.3.2 Genotyping 
Genotypes were determined through PCR analysis.  Standard reaction 
conditions were utilized in a total volume of 20 μl. The reaction parameters are as 
follows: 5 min denaturation at 95 oC; thirty five cycles of 95 oC for 30 seconds, 60 oC for 
30 seconds and 72 oC for 30 seconds, and a final elongation of 10 minutes at 72 oC.  
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The wild-type Smad3 allele was detected using primer 1 (5’-
CCACTTCATTGCCATATGCCCTG-3’) and primer 2 (5’-
CCCGAACAGTTGGATTCACACA-3’).  Primer 1 is located 5’ to the deletion and primer 
2 is located within the deletion. This primer pair amplifies a fragment of ~400 bp.  The 
mutant allele was visualized using primer 1 and primer 3 (5’-
CCAGACTGCCTTGGGAAAAGC-3’), which is located within the targeted insertion, 
resulting in a 250bp fragment.  The wild-type Tgif allele was detected using primer 4 (5’-
AGTCCAACTGGCCGGAATTGTCAC-3’) and primer 5 (5’- 
CCTCAGAGTCACTGCCTGATG-3).  Primer 4 is located within the first intron, 5’ to the 
deletion.  Primer 5 is located within the deletion, and together they produce a fragment 
of 558bp in length.  The mutant allele was amplified using primer 4 and primer 6 (5’-
TGGTGCAGATGAACTTCAGGGTGAG-3’), which is located within the targeted 
insertion, resulting in a 690 bp fragment.  The Smad2 mutant allele was detected using 
primer 7 (5’-GAGCTGCGCAGACCTGTTAC-3’) and primer 8 (5’-
GAAGGGGATCCCATCTGAGT-3’), which give a ~950bp fragment.  Primer 7 is 5’ to the 
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  Embryo Total  Abnormal Reduced Midbrain Midline 
  Genotype Embryos Embryos and Hindbrain Abnormalities
 Smad3 +/+ ; Tgif +/-  35 3 (9%) 3 (9%) 0 
  Smad3 +/+ ; Tgif -/-  21 3 (14%) 1 (5%) 2 (10%) 
 Smad3 +/- ; Tgif +/-  23 2 (9%) 2 (9%) 0 
  Smad3 +/- ; Tgif -/-    29 7 (24%) 2 (7%) 5 (17%) 
 Smad3 -/- ; Tgif +/-    11 2 (18%) 2 (18%) 0 
  Smad3 -/- ; Tgif -/-    11 4 (36%) 3 (27%) 1 (9%) 
  Totals 130 21 (16%) 13 (10%) 8 (6%) 
 
Table 2.1 Evaluation of E10.5 Smad3 ; Tgif embryos.  Embryos were obtained from 


















(based on E10.5 
percentages) 
 Smad3 +/+ ; Tgif +/-    6 0 0.5 0.5 
 Smad3 +/+ ; Tgif -/-    24 0 3.4 1.2 
 Smad3 +/- ; Tgif +/-    5 0 0.5 0.5 
 Smad3 +/- ; Tgif -/-    10 0 2.4 0.7 
 Smad3 -/- ; Tgif +/-    3 0 0.5 0.5 
 Smad3 -/- ; Tgif -/-    5 0 1.8 1.4 
 Totals 53 0 8.5 5.3 
 
Table 2.2 Evaluation of E11.5 Smad3; Tgif embryos.  Embryos were obtained from 
various crosses of Smad3 ; Tgif mice. 










Figure 2.1 Tgif expression pattern at E8.5 and E9.5.  The embryo on the left is E8.5 and 
exhibits Tgif expression along the anterior edge of the developing telencephalon (white arrow).  
The embryo on the right is E9.5 and exhibits Tgif expression in the prospective forebrain and 













Figure 2.2 Midbrain and hindbrain phenotype of E10.5 Smad3; Tgif mutants.  The 
embryo on the left is Smad3 +/- ; Tgif +/- and exhibits the reduced midbrain and hindbrain 
phenotype that has been attributed to a dissection artifact.  The embryo on the right is an 
aphenotypical littermate.  





 The diversity of functions that RA plays during development has led to a 
thorough examination of its properties.  One beneficial use that has come from studying 
RA is its effectiveness in treating acne and wrinkles (reviewed in [31]).  This in turn has 
led to a characterization of the much more negative teratogenic properties of RA 
(reviewed in [31]).  A fetus exposed to high amounts of RA can develop a number of 
defects including HPE, which has been shown in both humans and mice [32, 33].  It is 
also interesting that RXRα -/- mice are resistant to E11.5 exogenous exposure to RA 
[34].  Because of the previously mentioned evidence that Tgif is able to inhibit RXRα 
mediated signaling in vitro [11], it is hypothesized that Tgif may be required as a 
molecular brake on RA signaling during embryogenesis.  Thus mutations in Tgif may 
function in the development of HPE through an effective increase in endogenous RA 
signaling or loss of an embryo’s ability to respond to harmful levels of exogenous RA.  
In order to test this proposal, teratogenesis experiments were performed on mice with 
Tgif mutant and wild type backgrounds.  
 
3.1 Retinoic acid teratogenesis of Tgif mutants 
Pregnant females were intraperitoneally injected with a 7.5 mg/kg dosage of 
ATRA at E7.5 and embryos were observed at E10.5.  This protocol is an alteration from 
that used by Sulik et al. in their study displaying the ability of RA to cause HPE in mice 
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[33].  Crosses were set up to produce litters of the same genotype (Figure 3.1) in order 
to simplify genotyping due to the relatively small size of some of the abnormal embryos.  
Seven litters were observed for each genotype (Tgif wt, Tgif +/-, and Tgif -/-), totaling 183 
embryos.  A number of abnormalities were seen, including exencephaly, hindbrain, 
midbrain, and forebrain reductions, as well as axial defects and HPE (Figure 3.2).  The 
total percentage of abnormal embryos observed rose from 28% to 48% to 98% with the 
addition of Tgif mutant alleles (Table 3.1).  These results strongly suggest (p<0.01) that 
Tgif mutations in mice provide for an increased susceptibility to ATRA teratogenesis.  In 
order to reveal any changes in the occurrence of HPE due to differences in genotype, I 
separated the percentage of abnormal embryos into phenotypic subgroups (Figure 3.3).  
The percentage occurrence of HPE gradually increased from Tgif wt (2%) to Tgif +/- (7%) 
to Tgif -/- (12%) embryos.  Although these numbers are small, the increase in 
percentages from Tgif wt to Tgif +/- (p<0.001) and Tgif wt to Tgif -/- (p<0.001) are 
statistically significant.  The lack of statistical significance in the difference between  
Tgif +/- and Tgif -/- percentages (0.20<p<0.30) may be due to the small sample size, or it 
is possible that two Tgif mutations have no greater effect than one in the causation of 
HPE.  Nonetheless, these findings illustrate that Tgif mutations incur a predisposition 
specifically to the development of HPE through ATRA teratogenesis.  The importance 
behind this data is the characterization of a previously unknown genetic and 
environmental cooperation in the development of HPE.   
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3.2 Retinoic acid teratogenesis of Smad2 mutants 
Since Tgif mutations result in greater susceptibility to ATRA teratogenesis, and the 
combination of Tgif and Smad2 mutations provide for similar abnormalities, it is possible 
that Smad2 mutations also produce increased sensitivity to ATRA teratogenesis.  
Accordingly, experiments were performed using the same procedure as described for 
Tgif mutant embryos.  The exogenous ATRA caused abnormalities in 29% of wild type 
embryos and 76% of Smad2 +/- embryos (Dr. Tessa Carrel unpublished data).  The 
range of abnormalities was similar to those observed in the Tgif teratogenesis 
experiment, including exencephaly, delayed growth, pericardial ballooning, and HPE 
(Figure 3.4).  However, in this case HPE was seen at a much higher percentage in 
mutant embryos.  Such findings bolster the proposal that mutations in Smad2 and Tgif 
may act cooperatively to cause HPE through alterations in retinoid signaling.  These 




3.3 Materials and Methods 
 
3.3.1 Teratogenic application of retinoic acid 
 On E7.5, pregnant mice were injected intraperitoneally with 7.5 mg of 1 mg/ml 
retinoic acid in DMSO per kg of maternal body weight.  This concentration was obtained 
from previous analyses of RA teratogenesis in mice [33].  Embryos were then isolated 
at E9.5 or E10.5, photographed, and examined for phenotypes. 
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Tgif wt Tgif +/- Tgif -/-
 
Litters 7 7 7
Total Embryos 64 69 50
Normal Embryos 46 36 1
Abnormal Embryos 18 33 49
Percent Abnormal 28% 48% 98%  
Table 3.1 Summary of E10.5 Tgif embryos exposed to ATRA.  The total percentage of 
abnormalities seen in E10.5 embryos after ATRA treatment increased from 28% to 48% to 98% 
in Tgif wt, Tgif +/-, and Tgif -/- embryos respectively. 
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Figure 3.1 Tgif crosses for teratogenesis experiments.  Crosses were set up to ensure that 
each embryo of a single litter was the same genotype.  Pregnant mothers were intraperitonealy 
injected with 7.5mg of ATRA per 1kg of mother’s weight at E7.5.  Embryos were then observed 
for defects on E10.5. 
 
 





brain reduction axial 
defects
exencephaly HPE  
 
 
Figure 3.2 Phenotypes exhibited by E10.5 embryos exposed to ATRA.   Wide ranges of 
phenotypes and severity were observed at E10.5.  Some of the more common phenotypes 
include exencephaly (A), brain reductions (B, C), axial defects (D), and HPE (E). 
 
 








































Figure 3.3 Frequency of ATRA induced abnormalities.  Percentage of total embryos per 
genotype is plotted on the Y-axis.  Note: in this chart, percentages will not add to 100% because 




    normal HPE exencephaly delayed pericardial
          growth ballooning
Smad2 wt embryos  12 0 5 0 0 
  percentage 71% 0% 29% 0% 0% 
              
Smad2 +/- embryos  4 12 3 1 1 
  percentage 24% 70% 18% 6% 6% 
              
  Total number of litters 5         
 
Figure 3.4 Summary of E9.5 Smad2 embryos exposed to ATRA.  29% of wild-type and 
76% of Smad2 +/- embryos exhibit abnormalities after ATRA teratogenesis.  Analysis was 
performed by Dr. Tessa Carrel.






 The finding that Tgif mutations create a susceptibility to ATRA teratogenesis 
provides indirect evidence that Tgif acts as an inhibitor of RA signaling during 
embryogenesis.  Verifying this possibility requires a method for quantifying levels of 
retinoic acid signaling in the presence and absence of Tgif.  For this objective I 
employed a lacZ reporter gene whose expression is responsive to retinoid signaling, 
therefore allowing the direct visualization of this signaling.  The lacZ reporter system is 
commonly used for these purposes.  First, a β-galactosidase gene is fused to a 
promoter of interest.  Then, under conditions specific to the promoter, β-galactosidase is 
expressed.  Finally the β-galactosidase protein may be stained for, revealing the 
expression patterning of the promoter.  
 
4.1 Use of a retinoic acid responsive lacZ reporter to visualize retinoid 
signaling in Tgif mutants 
  The lacZ strain utilized for this project was obtained from Dr. Anthony LaMantia 
at the University of North Carolina at Chapel Hill.  This strain possesses a randomly 
inserted β-galactosidase gene under the control of an artificial promoter responsive to 
retinoid signaling. The promoter contains three tandemly fused RAREs taken from the 
RARβ-2 gene [35] (Figure 4.1).  It has been characterized in both mice and derived cell 
lines as responsive to ATRA [35].  In mice, embryos exposed to ATRA 14 hours before 
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staining showed an expanded region of RA signaling in the forebrain and tail at E9.5 
and E10.5 [35].  
 This strain was bred into the Tgif mutant background, and embryos were 
assayed for their RA signaling patterns and levels at E9.5 and E10.5 according to a 
protocol from Balkan et al. [36].  As seen in the characterization by Balkan et al., 
embryos at this stage produce a pattern of β-galactosidase expression in prospective 
forebrain.  This expression is absent along the midline of the prospective forebrain.  
Extensive expression also occurs along the dorsal midline, extending from the auditory 
vesicle to the end of the tail [35] (Figure 4.2).  This expression pattern is within the 
origins of the majority of abnormalities seen through ATRA teratogenesis, including 
HPE, forebrain reductions, and axial defects.   
Assuming that Tgif functions to inhibit RA signaling during embryogenesis, it is 
expected that a greater amount of LacZ expression will occur in embryos lacking one or 
two copies of Tgif.  These expectations were met to a certain extent at both E9.5 and 
E10.5 stages.  However, analysis became confusing when a small portion of Tgif wt 
embryos showed darker staining than Tgif +/- littermates, and likewise with Tgif +/- 
embryos compared to Tgif -/- littermates.  Upon further examination of the previously 
mentioned teratogenesis results, it appears that these observations are consistent and 
may even be expected.    
Figure 4.3 is another representation of the teratogenesis results.  Each bar 
represents the portions of normal and abnormal embryos from one of the three 
genotypes tested.  This data shows that 28% of Tgif wt embryos were susceptible to 
ATRA teratogenesis at the dosage administered.  Thus, even without Tgif mutations 
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there is an inherent susceptibility within 28% of wild-type embryos.  Furthermore, 48% 
of Tgif +/- embryos showed this susceptibility, where 52% remained normal.  As a 
consequence, it may be assumed that the 28% of wild-type embryos incurring 
abnormalities possessed a greater inherent susceptibility to ATRA teratogenesis than 
the 52% of Tgif +/- embryos that remained normal.  Assuming that greater endogenous 
levels of RA signaling serve as a readout for teratogenesis susceptibility, it is expected 
that 15% (28% x 52%) of Tgif wt : Tgif +/- comparisons will show greater staining in the 
wild-type embryo.  This assumption also reduces the expected number of Tgif wt : Tgif +/- 
comparisons with greater staining in the Tgif +/- embryo from the original 100% down to 
35% (48% x 72%).  These new expected values leave a large region of gray area 
because the number of abnormal Tgif +/- embryos expected to stain darker than 
abnormal Tgif wt embryos cannot be determined through the teratogenesis data.  This is 
the same for comparing the normal embryos as well.  Therefore, 50% (100% -15% - 
35%) of Tgif wt : Tgif +/- comparisons cannot be designated as expected greater staining 
in either embryo.   
With new expected values based on teratogenesis data, it is possible to test 
whether endogenous RA activity levels can predict the predisposition to developing 
abnormalities through exogenous exposure to ATRA.  For validity purposes, a strict 
system was set up to ascertain results.  Because small alterations in staining 
procedures as well as variances in embryo age result in noticeable differences in 
staining intensity, embryos were only compared with same-age littermates.  In a blind 
comparison, each embryo was paired with all other littermates and scored as darker or 
similar staining intensity.  Expanded boundaries of staining were also observed, but 
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always accompanied a darker intensity.  Next, genotypes were determined and 
comparisons were added together by genotype (Table 4.1).  Interestingly, pairings of 
embryos with the same genotype showed a good deal of variability.  To be exact, 29% 
of Tgif wt (n=14), 67% of Tgif +/- (n=21) and 50% of Tgif -/- (n=6) pairs displayed differing 
staining intensity.  The results for pairs of embryos with different genotypes were 
analyzed against the expected values obtained from the teratogenesis experiment 
represented in Chapter 3 in addition to values obtained from the recapitulation of this 
experiment by Bartholin et al. from Dr. David Wotton’s laboratory (Table 4.1).  The 
teratogenesis results vary because Bartholin et al. used gavage feeding to administer 
RA instead of intraperitoneal injections.  Although the same proportion of RA was given 
to pregnant mothers, gavage feeding allows for a smaller effective dose exposed to the 
embryos, resulting in a non-statistically significant increase in susceptibility from Tgif +/- 
to Tgif -/-.  After comparison of observed percentages to minimal expected percentages, 
only two of six pair groups showed greater β-galactosidase expression than the 
expected minimums from both sets of teratogenesis data.  These pair groups were the 
percentage of Tgif +/- embryos with greater expression than Tgif wt embryos (p<0.01) 
and Tgif -/- embryos with greater expression than Tgif wt embryos (p<0.005).  
Unfortunately the remaining percentages are too low to carry significance with the small 
number of parings observed.  However, it is clear that even with such a qualitative 
measure of RA signaling, there is an increase in basal levels of RA signal transduction 
in mouse embryos possessing one or more null alleles of Tgif.  These observations 
support the proposal that Tgif acts as an inhibitor of RA signaling during embryonic 
development.   
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4.2 Quantification of β-galactosidase expression in Smad2 mutants 
Because Smad2 mutations parallel Tgif mutations in their ability to increase 
sensitivity to ATRA teratogenesis, Smad2 likely acts as an inhibitor of RA signaling 
during development as well.  In order to investigate this possibility, the RA responsive 
lacZ reporter was bred onto the Smad2 mutant background.  A quantitative analysis of 
β-galactosidase expression was used to compare RA signaling levels between wild-type 
and Smad2 +/- embryos at E9.5 and E10.5.  As mentioned in Chapter 2, embryos 
homozygous for a null allele of Smad2 do not survive to the stage assayed in this 
analysis.  The protocol for quantification of β-galactosidase expression in cell extracts 
was taken from Balkan et al. [35].  Once embryos were removed from the mother, the 
heads were separated from the bodies and assayed.  The decapitation was used to 
avoid the flushing out of subtle differences in the head with the overpowering 
expression coming from the tail.  Subsequently, pair-wise comparisons were made 
between littermates according to the parameters of the previous experiment.  Results 
show that 72% (p<0.005) of pairs showed higher expression in the Smad2 +/- embryo, 
and 28% of pairs showed higher expression in the Smad2 wt embryo (Figure 4.4).  
These values were compared to expected values based on the teratogenesis 
experiments performed on Smad2 mutant embryos as described in Chapter 3 (Figure 
3.4).  Results correlate well with the 54% and 7% minimal expected values respectively 
(Figure 4.4).  Furthermore, when litters are examined individually, all but one show an 
upward trend between the mean β-galactosidase expression levels from wild-type to 
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Smad2 +/- embryos (Figure 4.5).   Finally, these results provide evidence for Smad2 as 
an inhibitor of retinoid signaling during embryogenesis. 
 
4.3 Materials and Methods 
 
4.3.1 Whole mount visualization of β-galactosidase expression 
 After dissection, embryos were fixed in 4% paraformaldehyde with 0.4% 
glutaraldehyde for 1-2 hours at 4 oC.  Embryos were then washed twice in 1X PBS.  
Next they were incubated for 45 minutes at room temperature in the absence of light in 
β-galactosidase staining media (5mM potassium ferricyanide, 5mM potassium 
ferrocyanide, 1.0mg/ml X-gal, 0.2% NP-40, 2mM MgCl2, diluted in 1X PBS).  Finally, 
embryos were washed twice with 1X PBS and photographed for comparison.   
 
4.3.2 Quantification of β-galactosidase expression 
 After dissection, embryo heads were removed just above the auditory vesicle and 
placed in 40μl of 1X PROMEGA Reporter Lysis Buffer.  After homogenization, 20μl 
were removed and added to 400μl of Z buffer (60mM Na2HPO4•7H2O, 40mM 
NaH2PO4•H2O, 10mM KCl, 1mM MgSO4, 0.27% β –mercaptoethanol, 4.3mM ONPG, 
pH to 7.0).  This solution was incubated at 37 oC for 6 hours.  The reaction was 
terminated with 200μl of 1M Na2CO3, and expression levels were calculated with a 
spectrophotometer by measuring the absorbancy at λ570.  These values were 
normalized with the protein concentration of each sample, which was measured using 
the Bio Rad DC Protein Assay. 




  Lasse Bartholin et al. 
 Observed Expected Expected 
Total Tgif wt : Tgif +/- Pairs 19   
Percent with Higher Expression Level in Tgif wt 5% (1) 15% 12% 
Percent with Higher Expression Level in Tgif +/- 79% (15) 35% 41% 
    
Total Tgif wt : Tgif +/- Pairs 32   
Percent with Higher Expression Level in Tgif +/- 9% (3) 1% 17% 
Percent with Higher Expression Level in Tgif -/- 28% (9) 51% 29% 
    
Total Tgif wt : Tgif +/- Pairs 10   
Percent with Higher Expression Level in Tgif wt 0% (0) 1% 9% 
Percent with Higher Expression Level in Tgif -/- 90% (9) 71% 50% 
Table 4.1 Comparison of endogenous levels of RA signaling in E9.5 and E10.5 Tgif 
mutant embryos.  Embryos possessing a retinoid signaling responsive lacZ reporter allele 
were stained for B-galactosidase expression at E9.5 and E10.5.  Littermates were compared in 
a blind fashion and scored as showing higher expression levels in either embryo or similar 
expression levels.  Percentages of observed pair differences are represented along with 
minimum expected percentages extrapolated from teratogenesis data performed by myself and 
Bartholin et al.  In parenthesis are the numbers of pairs that correspond to the accompanying 








Figure 4.1 Retinoic acid responsive lacZ reporter allele.  The arrows represent RARE 
sequences taken from the RARβ-2 promoter and are indicated as positioned forward or 
backward.  These are followed by a TK promoter, a β-galactosidase gene, and the construct 
ends with an SV40 intron plus polyadenylylation site.  Taken from [35]. 
 
 










Figure 4.2 Embryos carrying the RA responsive β-galactosidase allele after lacZ 
staining.  In this representative example, the Tgif +/- embryo on the left displays darker staining 





























Figure 4.3 Second representation of teratogenesis results.  
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  Minimum 
  Expected 
Total Smad2 wt vs. Smad2 +/- Pairs 36  
Percent With Higher Expression Level in Smad2 wt 28% (10) 7% 
Percent With Higher Expression Level in Smad2+/- 72% (26) 54% 
 
Figure 4.4 Comparison of endogenous levels of RA signaling in E9.5 and E10.5 Smad2 
mutant embryos.  Cranial tissue of embryos possessing a retinoid signaling responsive lacZ 
reporter allele was quantified for β-galactosidase expression at E9.5 and E10.5.  Percentages of 
observed pair differences are represented along with minimum expected percentages taken 
from teratogenesis data performed by Dr. Tessa Carrel.  In parenthesis are the numbers of pairs 

























 Smad2 wt Smad2 +/- 
 
Figure 4.5 Litterwise comparison of β-galactosidase expression in wild-type and Smad2 
mutant embryos.  Quantified β-galactosidase levels were normalized using the protein 
concentration of each sample, which correspond to the values on the Y-axis.  Embryos are 
separated by genotype.  Each embryo is represented by a symbol corresponding to the litter 
number, and black trend lines connect mean expression values of wild-type and Smad2 +/- 
embryos of each litter.  Four of five litters show higher mean expression in Smad2 heterozygous 
over wild-type embryos.








After demonstrating that haploinsufficiency of Smad2 increases susceptibility to 
ATRA teratogenesis, I proceeded to investigate a potentially novel interaction between 
TGF-β and retinoid signaling pathways.  If, as predicted from these observations, TGF-β 
signals are able to inhibit retinoid signaling through the TGF-β signal transducer Smad2, 
then there are a number of stages throughout the process of retinoid signaling that 
Smad2 may produce its affects.  The most likely of these stages is at the level of the 
retinoid receptors.  As mentioned in Chapter 1, the RAR and RXR families of proteins 
each contain three isoforms (α,β,γ) with a number of splicing variants (reviewed in [15]).  
The large number of possible heterodimers and homodimers provide a great deal of 
complexity, requiring an equivalent amount of regulation to carry out the variety of 
functions performed by RA signaling during development.  A 2003 publication by a 
group in Paris, France, showed that Smad3, highly homologous to Smad2, is able to 
bind RAR-γ in vitro [37].  This interaction was also shown to facilitate an enhancement 
of Smad3 dependent transcription [37].  Fortunately I was given the opportunity to travel 
to Paris and investigate the binding of Smad2 to RAR-γ in addition to the effect of 
Smad2 on retinoid dependent transcription.   
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5.1 Use of immunoprecipitation to assess physical interactions between 
Smad2 and RAR-γ proteins 
For the elucidation of any physical interaction between Smad2 and RAR-γ, both a 
Myc-tagged Smad2 and Gal4-tagged RAR-γ were overexpressed in 293T cells.  An 
immunoprecipitation assay was then performed, pulling down Gal4-RAR-γ and blotting 
for Myc-Smad2 with anti-Gal4 and anti-Myc antibodies respectively.  Unlike Smad3, 
however, no evidence was found for the interaction between Smad2 and RAR-γ (data 
not shown).  Dr. David Wotton’s group later repeated these results.   
As a direct result of my teratogenesis findings the Wotton group also tested 
interactions between Tgif and RAR or RXR proteins.  Not surprisingly, they showed a 
strong interaction between Tgif and RXR-α (Bartholin et al. unpublished data).  This 
interaction was found under conditions of overexpression and at endogenous levels.  
 
5.2 Use of semi-quantitative RT-PCR to measure Smad2 regulation of RAR 
and RXR transcription 
Despite ruling out a physical interaction between Smad2 and one of three retinoic 
acid receptors, many other possible methods remain for Smad2 to deliver its effects on 
retinoid signaling.  These effects may occur at the transcriptional, translational, or 
functional stages of retinoid receptor activity.  To this end, I decided to first investigate 
the ability of Smad2 to influence the transcription of the three RAR isoforms and three 
RXR isoforms.  Semi-quantitative RT-PCR techniques were utilized for this purpose.  
HepG2 cells were transiently transfected with Smad2 or an empty vector as a control, 
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and endogenous transcription levels of each of the RARs and RXRs were measured.  
Upregulation of Smad2 was verified through RT-PCR analysis, and primers for GAPDH 
were used to ensure even sample loading.  This assay also acts as a read-out for 
Smad2’s regulation of RA signaling, as many of the RAR’s and RXR’s contain retinoid 
responsive elements in their promoters [38].  After repeated attempts, it was determined 
that the levels of RAR and RXR transcript were unaltered by the presence of exogenous 
Smad2 (data not shown).   
 
5.3 Use of a retinoic acid responsive luciferase reporter to measure the 
affect of Smad2 on retinoid regulated transcription 
Finally, I decided to test the functional stage of RAR and RXR activity.  By 
observing the last step of retinoid receptor function, I should be able to elucidate 
whether Smad2 is able to influence RA signaling at any point upstream in the pathway.  
For this purpose, HepG2 and 293T cells were transiently transfected with an RA 
responsive luciferase reporter.  This reporter contains three tandemly repeated RAREs 
in its promoter, similar to the previously described RA responsive lacZ reporter and is 
likewise responsive to treatment with ATRA.  Luciferase activity was measured in the 
presence or absence of Smad2, Smad4, ATRA, and TGF-β ligand.  Expression of 
Smad2 and Smad4 were verified through western blotting (data not shown).  Despite 
apparent changes in luciferase activity in single experiments, such alterations were not 
consistently repeatable.  Thus it seems that Smad2 is unable to affect retinoid signaling 
in vitro.  These negative findings may be a context dependent result due to the cell 
types used or specific to the promoter chosen for the experiment.    
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5.4 Materials and Methods 
 
5.4.1 Cell Culture 
 HepG2 and 293T cells were grown in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% heat-inactivated fetal calf serum (FCS), 2mM 
glutamine and antibiotics (100 U/ml penicillin, 50 mg/ml streptomycin G, and 0.25 mg/ml 
FungizoneTM).  Cells were maintained at 37 oC in a 5% CO2 – 95% air atmosphere.   
  
5.4.2 Transient cell transfections 
 Transient cell transfections were performed using a jetPEI kit from QBIOGENE.  
In experiments requiring the addition of ATRA or TGF-β ligand, cultures were placed in 
DMEM containing 1% FCS before treatment.  Human recombinant TGF-β ligand was 
purchased from R&D Systems Inc.  All-trans retinoic acid (ATRA) was purchased from 
Sigma.  In every experiment an eGFP vector was cotransfected to monitor transfection 
efficiencies.   
 
5.4.3 Immunoprecipitation and western blotting 
 Myc-tagged Smad2 and Gal4-tagged RAR-γ expression vectors were transfected 
into 293T cells.  After 48 hours, cells were washed twice with cold 1X PBS, scraped, 
and dissolved in Buffer N (50mM Tris-HCl, pH 7.5, 150mM NaCl, 2mM EDTA, 1% NP-
40).  Lysates were then cleared of debris by centrifugation, and incubated with protein 
G-sepharose beads at 4 oC for 1 hour to remove non-specific binding proteins 
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(Amersham Biosciences).  Next they were incubated with an anti-Gal4 antibody (Santa-
Cruz Biotech) overnight at 4 oC, followed by another incubation with protein G–
sepharose beads at 4 oC for 1 hour.  After washing the pellet twice with buffer N and 
twice with PBS, immunoprecipitates were eluted by boiling for 3 minutes and subjected 
to SDS–polyacrylamide gel electrophoresis.  Proteins were then transferred to a 
nitrocellulose membrane and immunoblotted with an anti-Myc (Roche) antibody.  
Protein bands were visualized using the ECLplus Western Blotting Detction System® 
from Amersham Biosciences.  
 
5.4.4 Semi-quantitative RT-PCR 
 RNA extraction was performed using to the RNeasy® Mini Kit from QIAGEN.  
cDNA libraries were then prepared.  Semi-quantitative PCR was performed on the 
cDNAs to measure levels of RAR-α,β,γ and RXR-α,β,γ transcription.  Human gene 
sequences were obtained from www.ensembl.org.  RAR-α was amplified using 
published primers [39].  The remaining gene specific primers were designed using 
Primer Premier software from Biosoft International.  All primers were made to cross 
intron/exon boundaries. The primer sequences and product lengths are indicated in 
Table 5.1. Multiplex PCR was performed using the Multipex PCR Kit from QIAGEN.  
Products were separated by gel electrophoresis and visualized with ethidium bromide 
staining.  
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5.4.5 Luciferase assays 
 A synthetic retinoid responsive promoter tagged to a luciferase reporter gene 
was transfected into HepG2 and 293T cells along with vectors containing components 
of TGF-β signaling.  As an internal expression control, a vector containing the renilla 
reporter gene under the control of a TK-promoter was cotransfected in every 
experiment.  After 6 hours of incubation at 37 oC, cultures were placed in DMEM 
containing 1% FCS, at which time ATRA was added to designated cultures at a 
concentration of 1μM.  After 16 more hours of incubation, TGF-β ligand was added to 
designated cultures at a concentration of 5ng/ml.  After a final 2-hour incubation, cells 
were washed twice with 1X PBS and assayed for luciferase and renilla expression using 
the Luclite® and Renlite® Reporter Gene Assay Systems from PerkinElmer.  Smad2 and 
Smad4 vectors were tagged with a Flag epitope tag and expression was verified 
through western blotting as described above, using anti-Flag antibodies from Sigma. 
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Gene 
Name Forward Primer  Reverse Primer 
Product 
Length 
RXR-α 5’-ATACGTGGAGGCAAACATGG-3’ 5’-TAGCACCCTGTCAAAGATGG-3’ 307bp 
RXR-β 5’-GCAAGCACTATGGGGTTTAC-3’ 5’-TAGTCACTGGGTCATTTGGG-3’ 372bp 
RAR-α 5’-ATCGAGACCCAGAGCAGCAG-3’ 5’-CCTGGTGCGCTTTGCGAACC-3’ 420bp 
RAR-β 5’-CAGAAGTGCTTTGAAGTGGG -3’ 5’-AACACAAGGTCAGTCAGAGG-3’ 494bp 
RXR-γ 5’-AGACAGAATCCTACGGTGAC-3’ 5’-GTGTTCCAGGCATTTCAAGC-3’ 563bp 
RAR-γ 5’-AACTCATCACCAAGGTCAGC-3’ 5’-TTCTGCTCCCTTAGTGCTGA-3’ 623bp 
 











Many human birth defects have been studied through the use of mouse models.  
Holoprosencephaly (HPE), a range of forebrain and craniofacial abnormalities resulting 
in a high incidence of lethality, has been no exception.  Many teratogens and genetic 
mutations have been shown to cause HPE; one such teratogen is retinoic acid (RA).  
Exposure of pregnant females to exogenous RA has been observed to cause HPE in 
both humans and mice [32, 33].   
One gene that has been found mutated in a number of human cases of HPE is 
TGIF (TG interacting factor) (reviewed in [6]).  This gene encodes a homeobox domain 
protein, identified through its ability to repress RA signaling through binding of the 
retinoid X receptor response element [11].  Tgif also functions in TGF-β signaling [19].  
Interestingly, mice homozygous for null mutations in Tgif do not exhibit HPE.  However, 
teratogenesis experiments reveal that mutations in Tgif render mice more susceptible to 
ATRA teratogenesis.  This increased susceptibility relates to the total range of 
abnormalities caused by exogenous ATRA as well as the incidence of HPE specifically.   
These findings represent a novel cooperation between genetic and environmental 
factors in the development of HPE. 
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Using a lacZ reporter allele under the influence of a RA responsive promoter, I 
investigated whether the loss of Tgif or Smad2 is able to raise endogenous levels of 
retinoic acid signaling.  I found through visual analysis of β-galactosidase expression 
that a significant percentage of Tgif +/- and Tgif -/- embryos show greater RA signaling 
levels than wild-type littermates.  Using a β-galactosidase quantification assay, cranial 
RA signaling was measured in Smad2 embryos.  Again, a significant increase in 
signaling was found in Smad2 +/- compared to wild-type littermates.  These results 
support the in vitro evidence that Tgif acts as a repressor of RA signal transduction [11] 
and suggest a novel interaction between Smad2 and RA signaling.  Furthermore, 
greater levels of endogenous retinoid signaling may foreshadow increased susceptibility 
to ATRA teratogenesis, as suggested through the correlation of β-galactosidase 
expression comparisons with ATRA teratogenesis data.  However, greater numbers of 
pairs need to be observed to provide statistically significant evidence for this conclusion.   
Although a mechanism has already been proposed for the ability of Tgif to 
repress retinoid signaling ([11], Bartholin et al. unpublished data), Smad2 has not 
previously been characterized as having such activity.  Because the most likely point of 
retinoid signaling repression lies with the activity of the retinoid receptors, in vitro assays 
were designed to test this hypothesis.  Unfortunately, any mechanisms by which Smad2 
represses retinoid signaling remain elusive, as immunoprecipitations failed to 
demonstrate binding between Smad2 and RAR-γ, RAR and RXR transcription is not 
altered by the presence of Smad2, and Smad2 was unable to regulate the function of 
RARs and RXRs in the promotion of retinoid dependent transcription.   
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